NASDAQ: SGRYSURGERY PARTNERS INC Stock
$30.57+0.44 (+1.46%)
Updated Jun 24, 2022
SGRY Price
$30.57
Fair Value Price
$34.77
Market Cap
$2.75B
52 Week Low
$26.66
52 Week High
$68.25
P/E
-66.46x
P/B
2.37x
P/S
2.1x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.31B
Earnings
-$37.70M
Gross Margin
22.2%
Operating Margin
8.57%
Profit Margin
-1.6%
Debt to Equity
3.68
Operating Cash Flow
$117M
Beta
1.73
Next Earnings
Aug 2, 2022
Ex-Dividend
N/A
Next Dividend
N/A
SGRY Overview
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SGRY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SGRY ($30.57) is undervalued by 12.07% relative to our estimate of its Fair Value price of $34.77 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SGRY ($30.57) is not significantly undervalued (12.07%) relative to our estimate of its Fair Value price of $34.77 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SGRY is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SGRY due diligence checks available for Premium users.
SGRY News
Valuation
SGRY fair value
Fair Value of SGRY stock based on Discounted Cash Flow (DCF)
Price
$30.57
Fair Value
$34.77
Undervalued by
12.07%
SGRY ($30.57) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SGRY ($30.57) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SGRY is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SGRY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-66.46x
Industry
8.99x
Market
20.48x
SGRY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.37x
Industry
4.17x
SGRY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SGRY's financial health
Profit margin
Revenue
$596.2M
Net Income
$12.2M
Profit Margin
2%
SGRY's Earnings (EBIT) of $197.90M... subscribe to Premium to read more.
Interest Coverage Financials
SGRY's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$6.3B
Liabilities
$4.3B
Debt to equity
3.68
SGRY's short-term assets ($937.00M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SGRY's long-term liabilities ($3.73B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SGRY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SGRY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$79.8M
Investing
-$47.1M
Financing
-$43.7M
SGRY's operating cash flow ($116.70M)... subscribe to Premium to read more.
Debt Coverage Financials
SGRY vs Medical Care Facility Stocks
SURGERY PARTNERS Stock FAQ
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.